Hepion Pharmaceuticals, Inc. (HEPA) has 14 SEC Form 4 insider filings on record in the last 90 days. That includes 5 insider purchases totalling $825K. Most recent filing: Sept. 14, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 14, 2026 filed Sept. 3, 2026 | LoPriore Vincent S Executive Chairman | $0 | 12,500,000 | 0% | No | |
|
|
||||||
| Sept. 10, 2026 filed Aug. 19, 2026 | Purcell Michael J. Director | $0 | 299,000 | 0% | No | |
|
|
||||||
| Aug. 21, 2026 filed Aug. 19, 2026 | Stetz Gary S. Interim CEO | $0 | 1,345,500 | 0% | No | |
|
|
||||||
| Aug. 21, 2026 filed Aug. 19, 2026 | LoPriore Chase VP, Corp. Dev. | $0 | 1,345,500 | 0% | No | |
|
|
||||||
| Aug. 21, 2026 filed Aug. 19, 2026 | LoPriore Vincent S Executive Chairman | $0 | 1,345,500 | 0% | No | |
|
|
||||||
Showing the 5 most recent of 14 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free